Some Statistical Aspects of Pharmaceutical Content Uniformity

Article

Sampson, Charles B.; Breunig, H. Latham   (1971, ASQC)   Eli Lilly and Company, Indianapolis, IN

Journal of Quality Technology    Vol. 3    No. 4
QICID: 5090    October 1971    pp. 170-178
List $10.00
Member $5.00

FOR A LIMITED TIME, ACCESS TO THIS CONTENT IS FREE!
You will need to be signed in.
New to ASQ? Register here.

Article Abstract

Drug content uniformity among individual dosage units of pharmaceutical products has received increasing attention over recent years. Sampling plans and specifications set forth in the official compendia to which the industry is bound are attribute plans based upon variables measurements. These plans do not efficiently utilize all of the information available to the analyst nor do they include provisions for quantifying the decisions in a probabilistic sense. The authors consider procedures for correcting these shortcomings through combining both unit weight and quantitative assay data into alternative statements of information content which could be useful in evaluating pharmaceutical quality. Areas requiring further theoretical development are outlined.

Keywords

Pharmaceutical industry,Sampling plans,Degrees of freedom


Browse QIC Articles Chronologically:     Previous Article     Next Article

New Search

Featured advertisers





ASQ is a global community of people passionate about quality, who use the tools, their ideas and expertise to make our world work better. ASQ: The Global Voice of Quality.